6.91
Precedente Chiudi:
$6.98
Aprire:
$7.01
Volume 24 ore:
2,202
Relative Volume:
0.23
Capitalizzazione di mercato:
$19.45M
Reddito:
$20.92M
Utile/perdita netta:
$-25.87M
Rapporto P/E:
-0.3511
EPS:
-19.6815
Flusso di cassa netto:
$-15.02M
1 W Prestazione:
+1.62%
1M Prestazione:
+5.02%
6M Prestazione:
-15.36%
1 anno Prestazione:
-46.18%
Lifeward Ltd Stock (LFWD) Company Profile
Nome
Lifeward Ltd
Settore
Industria
Telefono
15082511154
Indirizzo
2 CABOT ROAD, HUDSON
Compare LFWD vs ABT, SYK, MDT, BSX, EW
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
|
LFWD
Lifeward Ltd
|
6.91 | 19.45M | 20.92M | -25.87M | -15.02M | -19.68 |
|
ABT
Abbott Laboratories
|
88.41 | 153.99B | 45.13B | 6.28B | 7.38B | 3.5895 |
|
SYK
Stryker Corp
|
307.80 | 118.00B | 25.27B | 3.34B | 4.57B | 8.6334 |
|
MDT
Medtronic Plc
|
79.34 | 101.86B | 36.36B | 4.84B | 5.43B | 3.7212 |
|
BSX
Boston Scientific Corp
|
45.29 | 67.32B | 20.62B | 3.56B | 3.48B | 2.3847 |
|
EW
Edwards Lifesciences Corp
|
87.36 | 50.30B | 6.30B | 1.07B | 1.09B | 1.8406 |
Lifeward Ltd Stock (LFWD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-02-10 | Iniziato | Laidlaw | Buy |
| 2017-04-03 | Downgrade | Barclays | Equal Weight → Underweight |
| 2016-12-16 | Iniziato | Oppenheimer | Outperform |
| 2016-07-15 | Iniziato | Piper Jaffray | Overweight |
| 2015-05-22 | Aggiornamento | Canaccord Genuity | Hold → Buy |
| 2015-05-08 | Reiterato | Barclays | Equal Weight |
| 2014-10-07 | Iniziato | Barclays | Equal Weight |
Mostra tutto
Lifeward Ltd Borsa (LFWD) Ultime notizie
Lifeward Ltd (LFWD) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Lifeward Ltd (LFWD) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Lifeward Ltd (LFWD) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
Lifeward Ltd (LFWD) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
Lifeward Ltd (LFWD) Institutional Confidence - TradingKey
Lifeward Ltd (LFWD) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
Lifeward Ltd (LFWD) Valuation: PE, PB & Fair Value Analysis - TradingKey
Lifeward Ltd (LFWD) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
Lifeward Ltd (LFWD) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Lifeward Ltd. (LFWD) Q1 2026 Earnings: Deep EPS Miss Tempered by Resilient Stock PerformanceProfit Warning Alert - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amidst Unreported RevenueROIC Trend Report - newsline.com
Lifeward Ltd. (LFWD) Hovers Near Support as Minimal Downside Move Signals CautionLarge Cap Trends - newsline.com
Lifeward Ltd. (LFWD) Holds Steady Near Support Amid Quiet Trading SessionSector Leader Stocks - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Weighs on StockEPS Consistency Score - newsline.com
LFWD Q1 2026 Earnings: Significant EPS Miss Amid Challenging QuarterGuidance vs Actual - newsline.com
LFWD Technical Analysis | Trend, Signals & Chart Patterns | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD News | LIFEWARD LTD (NASDAQ:LFWD) - ChartMill
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin, Revenue Not DisclosedEPS Revision Trend - newsline.com
Lifeward Q1 2026 Earnings: Significant EPS Miss Reflects Continued InvestmentEarnings Cycle Report - The Legal Advocate
LFWD Q1 2026 Earnings: EPS Misses Estimates by Wide Margin as Company Faces ChallengesMid-Term Outlook - newsline.com
Why Is Lifeward Ltd. (LFWD) Stock Down Today? - Meyka
Lifeward Ltd. (LFWD) Edges Higher as Support Holds, Resistance in FocusParabolic SAR - The Legal Advocate
Lifeward Ltd. (LFWD) Gains Ground: Testing Key Resistance at $7.48Death Cross - newsline.com
H.C. Wainwright Maintains Lifeward(LFWD.US) With Buy Rating, Maintains Target Price $10 - Moomoo
Lifeward Ltd. (LFWD) Nears Key Support Amid Modest DeclineSupport Level Bounce - newsline.com
Lifeward Ltd. (LFWD) Surges Over 11% as Shares Test Key ResistanceVolatility Stop - The Legal Advocate
Lifeward (LFWD) Q4 2025 Earnings Transcript - AOL.com
Lifeward’s Earnings Call Balances Setbacks and Strategy - The Globe and Mail
Lifeward (Nasdaq: LFWD) posts wider Q1 loss, adds Oratech and new convertible debt - Stock Titan
Lifeward (LFWD) Chief Medical Officer receives 15,000-share RSU award - Stock Titan
Lifeward (LFWD) Chief Medical Officer discloses 2,083 ordinary shares - Stock Titan
Lifeward promotes Keith Rose to chief medical officer By Investing.com - Investing.com Nigeria
Lifeward Ltd. Appoints Keith D. Rose, M.D. as Chief Medical Officer – SEC 8-K Filing May 2026 - Minichart
Lifeward appoints Keith D. Rose, M.D. as chief medical officer By Investing.com - Investing.com Australia
Lifeward appoints Keith D. Rose, M.D. as chief medical officer - Investing.com
Lifeward Names Keith D. Rose as Chief Medical Officer - TipRanks
Lifeward (NASDAQ: LFWD) appoints Keith D. Rose, M.D. as new CMO - Stock Titan
Lifeward promotes Keith Rose to chief medical officer - Investing.com
Lifeward Appoints Dr. Keith D. Rose as Chief Medical - GlobeNewswire
Lifeward Ltd.16079622026 - SEC.gov
Lifeward (LFWD) price target decreased by 37.93% to 4.59 - MSN
How The Lifeward (LFWD) Story Is Shifting With New Price Targets And Valuation Assumptions - Yahoo Finance
Lifeward Ltd (LFWD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Seizing Growth Opportunities - GuruFocus
Lifeward Earnings Call Balances Growth With Disruptions - The Globe and Mail
Number of shareholders of Lifeward Ltd. – BOATS:LFWD - TradingView
Lifeward Q1 earnings preview - MSN
Earnings Call Summary | Lifeward(LFWD.US) Q1 2026 Earnings Conference - 富途牛牛
Lifeward 1Q Loss/Shr $6.70 >LFWD - Moomoo
Lifeward Q1 2026 Loss Deepens: -$3.13/Share vs -$0.34 Expected - AlphaStreet
Lifeward Ltd (LFWD) Q1 2026 Earnings Miss: EPS -$6.70 vs -$1.26 - GuruFocus
Lifeward Ltd Azioni (LFWD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):